Known that the alterations in astrocytes and microglia are present in patients with PD and that these cell populations remain activated even after 30 days from TBI [42], we have shown that treatment with H, C and especially with their combination was able to reduce the activation of both GFAP and Iba-1 in the midbrain. The gene discussed is GFAP; the disease is Parkinson disease.